Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Andrew M Philip, Stephen D Anesi, C Stephen Foster & Peter Chang. (2022) Ocular Inflammatory Complications of Treatment for Metastatic Melanoma. Ocular Immunology and Inflammation 0:0, pages 1-5.
Read now
Read now
Busra Yilmaz Tugan, Berna Ozkan & Ozlem Sonmez. (2021) Recurrent Episodes with Serous Retinal Detachment and Anterior Uveitis in a Patient Using Nivolumab (Anti -PD-1 Antibody) Therapy: A case report and literature review. Seminars in Ophthalmology 36:8, pages 794-799.
Read now
Read now
Marcos Mozo Cuadrado, Laura Tabuenca Del Barrio & Esther Compains Silva. (2021) Bilateral Drug-Induced Uveitis and Epiretinal Membrane during the Treatment of a Metastatic Cutaneous Melanoma. Ocular Immunology and Inflammation 29:3, pages 543-545.
Read now
Read now
Pol Specenier. (2021) Cost-effectiveness of nivolumab in advanced melanoma: a drug review. Expert Review of Pharmacoeconomics & Outcomes Research 21:1, pages 13-28.
Read now
Read now
Michel M. Sun$suffix/text()$suffix/text(), Ralph D. Levinson$suffix/text()$suffix/text(), Artur Filipowicz$suffix/text()$suffix/text(), Stephen Anesi$suffix/text()$suffix/text(), Henry J. Kaplan$suffix/text()$suffix/text(), Wei Wang$suffix/text()$suffix/text(), Debra A. Goldstein$suffix/text()$suffix/text(), Sapna Gangaputra$suffix/text()$suffix/text(), Robert T. Swan$suffix/text()$suffix/text(), H. Nida Sen$suffix/text()$suffix/text() & Lynn K. Gordon$suffix/text()$suffix/text(). (2020) Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition. Ocular Immunology and Inflammation 28:2, pages 217-227.
Read now
Read now
Pol Specenier. (2018) Nivolumab in squamous cell carcinoma of the head and neck. Expert Review of Anticancer Therapy 18:5, pages 409-420.
Read now
Read now
Omar Abdel-Rahman, Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Meinrad Mannhart, Arianeb Mehrabi, Othmar Schöb & Anwar Giryes. (2017) Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert Review of Anticancer Therapy 17:4, pages 387-394.
Read now
Read now
Articles from other publishers (26)
Periklis Giannakis, Mohsan Malik, Sukaina Rashid & Eleni Vrizidou. (2023) Unilateral Posterior Uveitis in a Patient Receiving Nivolumab for Malignant Melanoma. Cureus.
Crossref
Crossref
A. Martens, P. P. Schauwvlieghe, A. Madoe, I. Casteels & S. Aspeslagh. (2023) Ocular adverse events associated with immune checkpoint inhibitors, a scoping review. Journal of Ophthalmic Inflammation and Infection 13:1.
Crossref
Crossref
Florence Chaudot, Pascal Sève, Antoine Rousseau, Alexandre Thibault Jacques Maria, Pierre Fournie, Pierre Lozach, Jeremy Keraen, Marion Servant, Romain Muller, Baptiste Gramont, Sara Touhami, Habeeb Mahmoud, Pierre-Antoine Quintart, Stéphane Dalle, Olivier Lambotte, Laurent Kodjikian & Yvan Jamilloux. (2022) Ocular Inflammation Induced by Immune Checkpoint Inhibitors. Journal of Clinical Medicine 11:17, pages 4993.
Crossref
Crossref
Tian Xia, Alexander J Brucker, Brendan McGeehan & Brian L VanderBeek. (2022) Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database. British Journal of Ophthalmology 106:1, pages 87-90.
Crossref
Crossref
Aditya Rali, Ye Huang & Steven Yeh. (2022) Cancer Immunotherapy and Uveitis: Balancing Anti-Tumor Immunity and Ocular Autoimmunity. International Ophthalmology Clinics 62:3, pages 49-63.
Crossref
Crossref
Supriya Arora, Thamolwan Surakiatchanukul, Tarun Arora, Marie Helene Errera, Hitesh Agrawal, Marco Lupidi & Jay Chhablani. (2022) Retinal toxicities of systemic anticancer drugs. Survey of Ophthalmology 67:1, pages 97-148.
Crossref
Crossref
Carmen Alba-Linero & Emilio Alba. (2021) Ocular side effects of checkpoint inhibitors. Survey of Ophthalmology 66:6, pages 951-959.
Crossref
Crossref
Julia Canestraro, Anna Do, Seth D. Potash, Joseph Panarelli, Meghan Berkenstock, David H. Abramson & Jasmine H. Francis. (2021) Immune checkpoint inhibitor associated ocular hypertension (from presumed trabeculitis). American Journal of Ophthalmology Case Reports 23, pages 101125.
Crossref
Crossref
O.D. Ostroumova, E.V. Chikh, E.V. Rebrova, A.Yu. Ryazanova, L.R. Panteleeva, G.Sh. Arzhimatova & L.K. Moshetova. (2021) Drug-induced uveitis. Vestnik oftal'mologii 137:1, pages 94.
Crossref
Crossref
Christopher R. Dermarkarian, Nimesh A. Patel, Victor M. Villegas & J. William Harbour. (2020) Bilateral uveitis associated with nivolumab therapy for metastatic non-small cell lung cancer. American Journal of Ophthalmology Case Reports 18, pages 100691.
Crossref
Crossref
Arthi Ganesh Venkat, Sruthi Arepalli, Sumit Sharma, Naveen Karthik, Careen Lowder, Justis P Ehlers, Arun Singh, Jeffrey Goshe & Sunil Srivastava. (2020) Local therapy for cancer therapy-associated uveitis: a case series and review of the literature. British Journal of Ophthalmology 104:5, pages 703-711.
Crossref
Crossref
Kristin Biggee. 2020. Uveitis. Uveitis
1
16
.
Mohammad Telfah, Thomas J. Whittaker & Gary C. Doolittle. (2019) Vision loss with pembrolizumab treatment: A report of two cases. Journal of Oncology Pharmacy Practice 25:6, pages 1540-1546.
Crossref
Crossref
Sara Touhami, Isabelle Audo, Céline Terrada, Alain Gaudric, Phuc LeHoang, Valérie Touitou & Bahram Bodaghi. (2019) Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis. Progress in Retinal and Eye Research 72, pages 100761.
Crossref
Crossref
Kevin C. Conlon, E. Lake Potter, Stefania Pittaluga, Chyi-Chia Richard Lee, Milos D. Miljkovic, Thomas A. Fleisher, Sigrid Dubois, Bonita R. Bryant, Michael Petrus, Liyanage P. Perera, Jennifer Hsu, William D. Figg, Cody J. Peer, Joanna H. Shih, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer & Thomas A. Waldmann. (2019) IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion. Clinical Cancer Research 25:16, pages 4945-4954.
Crossref
Crossref
Karen Bitton, Jean-Marie Michot, Emmanuel Barreau, Olivier Lambotte, Oscar Haigh, Aurélien Marabelle, Anne-Laure Voisin, Christine Mateus, Anne-Laure Rémond, Chloé Couret, Stéphane Champiat, Marc Labetoulle & Antoine Rousseau. (2019) Prevalence and Clinical Patterns of Ocular Complications Associated With Anti-PD-1/PD-L1 Anticancer Immunotherapy. American Journal of Ophthalmology 202, pages 109-117.
Crossref
Crossref
Wei Wang, Wai-Ching Lam & Ling Chen. (2018) Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma. Cancer Immunology, Immunotherapy 68:1, pages 85-95.
Crossref
Crossref
Ömer Kartal & Erman Ataş. (2018) Bilateral Optic Neuritis Secondary to Nivolumab Therapy: A Case Report. Medicina 54:5, pages 82.
Crossref
Crossref
Ramana S. Moorthy, Meena S. Moorthy & Emmett T. Cunningham. (2018) Drug-induced uveitis. Current Opinion in Ophthalmology 29:6, pages 588-603.
Crossref
Crossref
Lauren A. Dalvin, Carol L. Shields, Marlana OrloffTakami SatoJerry A. Shields. (2018) CHECKPOINT INHIBITOR IMMUNE THERAPY. Retina 38:6, pages 1063-1078.
Crossref
Crossref
A.-L. Rémond, E. Barreau, P. Le Hoang & B. Bodaghi. (2018) Uvéite bilatérale associée à un traitement par nivolumab. Journal Français d'Ophtalmologie 41:6, pages 536-539.
Crossref
Crossref
. (2018) Nivolumab. Reactions Weekly 1697:1, pages 298-298.
Crossref
Crossref
Christopher D. Conrady, Marissa Larochelle, Paula Pecen, Alan Palestine, Akbar Shakoor & Ajay Singh. (2017) Checkpoint inhibitor-induced uveitis: a case series. Graefe's Archive for Clinical and Experimental Ophthalmology 256:1, pages 187-191.
Crossref
Crossref
Mary Elizabeth Davis & Jasmine H. Francis. (2017) Cancer Therapy with Checkpoint Inhibitors: Establishing a Role for Ophthalmology. Seminars in Oncology Nursing 33:4, pages 415-424.
Crossref
Crossref
Hiroaki Kanno, Kyoko Ishida, Wataru Yamada, Takashi Nishida, Nobumichi Takahashi, Kiyofumi Mochizuki, Yuki Mizuno, Kanako Matsuyama, Tomoko Takahashi & Mariko Seishima. (2017) Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient. Journal of Infection and Chemotherapy 23:11, pages 774-777.
Crossref
Crossref
Takafumi KADONO. (2017) Immune-related adverse events by immune checkpoint inhibitors. Japanese Journal of Clinical Immunology 40:2, pages 83-89.
Crossref
Crossref